Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1.Written signed and dated informed consent (patient or LAR). <br/ >2.Either gender, in the age group between 18 to 65 years <br/ >3.Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4.A score of between 3 to 5 on the WHO Modified Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5.SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6.Patients who provide a agree to abide by the study requirements

1.Written signed and dated informed consent (patient or LAR). <br/ >2.Either gender, in the age group between 18 to 65 years <br/ >3.Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4.A score of between 3 to 5 on the WHO Modified Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5.SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6.Patients who provide a agree to abide by the study requirements

Nov. 13, 2021, 5:33 p.m. oms

Oct. 26, 2020, 8:29 a.m. oms

1.Written signed and dated informed consent (patient or LAR). <br/ >2.Either gender, in the age group between 18 to 65 years <br/ >3.Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4.A score of between 3 to 5 on the WHO Modified Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5.SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6.Patients who provide a agree to abide by the study requirements

1.Written signed and dated informed consent (patient or LAR). <br/ >2.Either gender, in the age group between 18 to 65 years <br/ >3.Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4.A score of between 3 to 5 on the WHO Modified Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5.SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6.Patients who provide a agree to abide by the study requirements